| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 460.542 | 91 |
| GSM780708 | Untreated after 4 days (C2_1) | 317.009 | 88 |
| GSM780709 | Untreated after 4 days (C3_1) | 295.067 | 87 |
| GSM780719 | Untreated after 4 days (C1_2) | 466.478 | 91 |
| GSM780720 | Untreated after 4 days (C2_2) | 382.144 | 89 |
| GSM780721 | Untreated after 4 days (C3_2) | 316.36 | 88 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 309.396 | 88 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 411.608 | 90 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 418.092 | 90 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 287.356 | 87 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 471.44 | 91 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 426.426 | 90 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 472.783 | 91 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 380.303 | 89 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 474.346 | 91 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 473.365 | 91 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 400.873 | 90 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 454.666 | 91 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 534.765 | 92 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 470.143 | 91 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 394.988 | 90 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 446.125 | 91 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 430.299 | 90 |